Elite Pharmaceuticals Inc (ELTP)

[mrwrn2010]

Listened to the replay of the call this evening. IMO, Nasrat and/or crew is very shrewd in a variety of ways:

Selling the opioid ANDAs when they thought the legal landscape was murky AND we needed capital, then looking into it further and buying them back now that we have more capital and it’s not as risky to launch.

Seeing the upcoming need for the additional facility and putting it in motion before we’re pinched.

Seeing the cost of NDAs, knowing Elite’s financial track record and pivoting the company strategy to large market ANDAs instead.

Finding the creative solution of rearranging the packaging lines/storage in the new facility vs building new or other more expensive options.

Buying the main facility when the lease was up vs moving elsewhere (more expensive).

Pulling the trigger on the Elite label, putting things in motion before Lannett ended our partnership. Could’ve been really screwed if he wasn’t preparing for it for months ahead of time.

I think he sees some of these dumb CC questions and is like “wtf 5 straight years of increasing metrics, gtfo with these dumb Q’s.” I’d probably be irritated too.

He’s certainly not perfect, but I feel like he’s implemented a number of creative, thinking-outside-the-box solutions to problems where others might’ve just gone into debt, or taken the more expensive, more conventional route. JMHO.